<DOC>
	<DOCNO>NCT00172211</DOCNO>
	<brief_summary>Patients affect end-stage renal disease ( ESRD ) subject enhanced oxidative stress , result reduce anti-oxidant system increase pro-oxidant activity . Besides , insulin resistance also common ESRD patient . Both enhance oxidative stress insulin resistance increase risk atherosclerosis cardiovascular mortality , intention reduce oxidative stress insulin resistance important ESRD patient suffer high cardiovascular risk . The high concentration glucose glucose degradation product ( GDP ) , high lactate , low pH conventional peritoneal dialysis ( PD ) solution know bioincompatible factor , believe increase oxidative stress PD patient . Physioneal® , biocompatible dialysis solution neutral pH , physiologic bicarbonate concentration low GDP level , apply Europe several year . Previous study Physioneal® reveal advantage improve infusion pain , efficient acid-base control , increase ultrafiltration , reduce peritonitis duration . However , effect oxidative stress insulin resistance peritoneal dialysis patient report yet . The comparison oxidative stress insulin resistance use Physioneal® may help elucidate possibly beneficial effect uremic patient , frequently suffer increase oxidative stress insulin resistance . Thirty continuous ambulatory peritoneal dialysis ( CAPD ) patient select study , receive conventional solution ( Dianeal® PD-2 PD-4 ) baseline period 3 month . Then Physioneal® use 3 month . Clinical condition , biochemical hematological parameter , oxidative marker blood effluent , insulin resistance measure baseline , Physioneal® , marker measure 1 month discontinue Physioneal® change back conventional solution . The medication use patient record , dialysis prescription adjust nephrologist accord clinical data . The data collect Physioneal® analyze paired-t test .</brief_summary>
	<brief_title>Comparison Oxidative Stress Insulin Resistance Before After Using Physioneal Peritoneal Dialysis Patients</brief_title>
	<detailed_description>Patients affect end-stage renal disease ( ESRD ) subject enhanced oxidative stress , result reduce anti-oxidant system increase pro-oxidant activity . Enhanced oxidative stress uremic patient increase risk atherosclerosis cardiovascular mortality . Furthermore , bioincompatibility dialysis therapy increase oxidative stress . High concentration glucose , high lactate , low pH , and/or high concentration glucose degradation product ( GDP ) know bioincompatible factor believe increase oxidative stress peritoneal dialysis patient . A biocompatible dialysis solution , i.e. , neutral pH , contain physiologic concentration bicarbonate low concentration GDP develop . There grow body vitro study show neutral bicarbonate contain dialysis solution biocompatible compare conventional solution . However , effect oxidative stress peritoneal dialysis patient report yet . On hand , insulin resistance associate cardiovascular disease , common uremic patient . Some animal study suggest reduced oxidative stress enhance insulin sensitivity , effect reduce oxidative stress human extensively investigate . Previous study Physioneal® , kind biocompatible dialysis solution contain bicarbonate , reveal advantage improve infusion pain , efficient acid-base control , increase ultrafiltration , reduce peritonitis duration . The comparison oxidative stress insulin resistance use Physioneal® , may help elucidate possibly beneficial effect uremic patient , frequently suffer increase oxidative stress insulin resistance .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Older 18 year old , young 70 year old 2 . Nondiabetic ESRD patient , e.g . chronic glomerulonephritis , hypertensive nephrosclerosis , interstitial nephritis , polycystic kidney disease , etc . 3 . Undergoing CAPD least 3 month le 60 month 4 . Kt/Vurea ( normalized Watson 's method ) great 1.7 , serum albumin great 3.5 g/dL 1 . Unstable clinical condition evidence malignancy 2 . Diabetes mellitus 3 . Pregnancy 4 . Have peritonitis recent 3 month active bacterial infection 5 . Taking medication know markedly interfere oxidative stress , e.g . large dose vitamin C ( great 500 mg/day ) vitamin E ( great 400 IU/day ) . 6 . Medical history systemic lupus erythematosus rheumatoid arthritis 7 . Serum potassium le 3.0 mEq/l 8 . Participate another study would interfere outcome study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Physioneal</keyword>
	<keyword>Peritoneal dialysis</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>insulin resistance</keyword>
</DOC>